文献速递类风湿关节炎

类风湿关节炎疾病活动度与无菌性假体松动风险

Rheumatoid arthritis disease activity and the risk of aseptic arthroplasty loosening.
PubMed 文献 · Semin Arthritis Rheum · 2019-08-01

该研究评估类风湿关节炎(RA)疾病活动度对全髋/全膝关节置换术后无菌性松动风险的影响。49例RA患者中18例(36.7%)出现影像学组件松动(RCL),随时间平均SDAI每增加1单位RCL风险显著增加(HR 1.125,95%CI 1.021-1.241;P=0.018);生物制剂治疗者RCL风险低于传统DMARDs(HR 0.192,95%CI 0.042-0.891;P=0.035);88例匹配骨关节炎(OA)患者RCL率13.6%,显著低于RA组(P=0.002)。

要点

  • 生物制剂治疗者RCL风险显著低于传统DMARDs治疗者。
  • OA对照组RCL率13.6%,显著低于RA组,支持炎症活动度的作用。

核心结论

  • 较高的炎症性疾病活动度增加RA患者全髋/全膝关节置换术后影像学松动的风险。
  • OA患者RCL率显著更低,进一步提示炎症性疾病活动度的潜在作用。
  • 在达标治疗背景下,存在关节假体可被视为更严格控制疾病活动度的指征。

研究设计与样本

  • 研究纳入接受全髋/全膝关节置换术的RA患者,用简化疾病活动指数(SDAI)评估疾病活动度。
  • 以影像学组件松动(RCL)征象估计无菌性松动风险,采用Cox回归基于SDAI估计RCL并对治疗进行调整。
  • 另设2:1匹配的骨关节炎(OA)患者队列作为无全身性炎症的对照组。

主要发现

  • 49例有全髋/膝关节置换史的RA患者中,18例(36.7%)出现RCL。
  • RCL患者随时间SDAI显著更高(中位数:10.8个月;第25和75百分位:8.6和15.8;对比7.0个月;2.7和15.5;P=0.043)。
  • 回归模型中,随时间平均SDAI每增加1单位显著增加RCL风险(HR 1.125,95%CI 1.021-1.241;P=0.018)。
  • 生物制剂治疗者RCL风险低于传统DMARDs治疗者(HR 0.192,95%CI 0.042-0.891;P=0.035)。
  • 88例匹配OA患者RCL率为13.6%,显著低于RA组(P=0.002)。

临床怎么用

  • 对携带关节假体的RA患者,可考虑将更严格的疾病活动度控制作为临床管理策略。
  • 生物制剂治疗与较低的RCL风险相关,但需结合患者具体情况个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the influence of rheumatoid arthritis (RA) disease activity (DA) on the risk of aseptic loosening after total hip/knee arthroplasty (THA/TKA). METHODS: We identified RA patients who underwent THA/TKA and determined their DA using the simplified disease activity index (SDAI). The risk of aseptic loosening was estimated using radiographic signs of component loosening (RCL). We performed Cox regression to estimate RCL based on SDAI, adjusting for therapy. We also investigated a cohort of 2:1 matched osteoarthritis (OA) patients as a control group without systemic inflammation. RESULTS: We identified 49 RA patients with a history of THA/TKA, of whom 18 (36.7%) showed RCL. SDAI over time was significantly higher in patients with RCL (median; 25th and 75th percentile: 10.8 months; 8.6 and 15.8; vs 7.0 months; 2.7 and 15.5;p = 0.043). In the regression model, each unit of mean SDAI over time significantly increased the risk of RCL (HR 1.125, 95% CI 1.021-1.241;p = 0.018). Patients treated with biological had a lower risk of RCL than those treated with traditional DMARDs (HR 0.192, 95% CI 0.042-0.891;p = 0.035). In the 88 matched OA patients, the RCL rate was significantly lower than in the RA group (13.6%;p = 0.002). CONCLUSION: Higher inflammatory DA increases the risk for radiographic loosening after THA/TKA in patients with RA. The significantly lower risk in patients with OA further underlines the potential role of inflammatory DA. In the context of treating RA to target, the presence of an arthroplasty might be considered as an indication for more stringent control of DA.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Böhler C, Weimann P, Alasti F, et al. Rheumatoid arthritis disease activity and the risk of aseptic arthroplasty loosening. Semin Arthritis Rheum. 2019. PMID: 31471012. doi:10.1016/j.semarthrit.2019.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。